ArticleBMC urology2024

Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy.

Jianjun Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.